Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QBKPN SSI in Second Primary Lung Adenocarcinoma
NCT02256852Phase 2Completed
- Sponsor
- Qu Biologics
- Start
- Dec 2014
- Primary completion
- Nov 2015
- Modality
- Prophylactic Vaccines, Microbiome Therapeutics, Therapeutic Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of QBKPN in non-small cell lung cancer (NSCLC), sponsored by Qu Biologics. Started Dec 2014; status: completed.
02
Drugs
QBKPN
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02256852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02256852.